Aclarion rises on commercial agreement with Scripps Health
03/03/2025 11:44
** Shares of healthcare technology co Aclarion ACON.O rise 68% to $5.61 premarket ** Co says it has entered into commercial agreement with Scripps Health ** The agreement will bring ACON's Nociscan, a tool that helps physicians personalize treatment for chronic low back pain, to Scripps' physicians in California ** In the last 12 months, ACON has fallen nearly 98% (Reporting by Siddhi Mahatole) ((Siddhi.mahatole@thomsonreuters.com))
Recent news on Aclarion
See all newsBrief: Aclarion Provides Update On Strength Of Company Positioning Following Q1 Strategic Initiatives
Brief: Aclarion Announces Reverse Stock Split
Brief: Aclarion provides shareholder update, to file 10K by March-end
U.S. STOCKS ON THE MOVE-Fastenal, Target Hospitality , Encore Capital
Brief: Aclarion Announces Expansion Plans With RadNet Affiliates In New York And New Jersey